Category: Vaccines
AlJazeera: WHO approves trials for two new Ebola vaccines
The World Health Organization (WHO) has approved clinical trials for two new Ebola vaccines, as doctors fight to control the largest outbreak in the history of the Democratic Republic of the Congo (DRC).
Nov 5, 2026
Reuters: Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK government
Bavarian Nordic has received a four-year contract from the British government for its vaccine against mpox and smallpox.
Nov 2, 2026
Medscape: Real-World Data Support Maternal RSV Vaccination
Immunization during pregnancy with the bivalent respiratory syncytial virus (RSV-A/B) prefusion F subunit (RSVpreF) vaccine was associated with significant protection for infants against hospitalization for RSV infection in the first 6 months of life, based on data from a new systematic review and meta-analysis presented at the Infectious Disease Week (IDWeek) 2026 Annual Meeting.
Nov 2, 2026
Medscape: Without Flu Vaccination, the US Could See Substantially More Deaths and Hospitalizations Annually
Influenza would likely cause more than 11,000 estimated deaths and more than 141,000 estimated hospitalizations each year without flu vaccination in the US, according to a modeling study presented at IDWeek in Washington on October 22.
Oct 29, 2026
Reuters: Research organization IAVI receives US funding for Ebola vaccine development
IAVI, a biomedical research organization, said on Wednesday it was awarded $36 million under a U.S. government contract worth up to $99 million to advance development of its single-dose vaccine candidate against the Bundibugyo strain of the Ebola virus.
Oct 29, 2026
ABC: FDA approves Moderna’s mRNA seasonal flu vaccine
The Food and Drug Administration approved Moderna’s mRNA seasonal flu vaccine on Wednesday. The vaccine, mFLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
Oct 27, 2026
STAT: After a cancer vaccine’s first success, the race is on to expand the impact
With the first pivotal trial showing a customized mRNA treatment improved outcomes for cancer patients presented here this weekend, the conversation has already turned to how melanoma specialists should adopt the medicine — and how widely these novel vaccines can be deployed.
Oct 27, 2026